Menopause and Oral Microbiome

Menopause Clinical Trial

Official title:

Evaluation of Dental Plaque and Saliva Microbiome and Their Association With Periodontal Parameters in Premenopausal and Postmenopausal Women

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05335733
• Other study ID #: EGE BAP-23832
• Status: Completed
• Start date: February 15, 2022
• Est. completion date: October 30, 2023

Study information

• Verified date: December 2023
• Source: Ege University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The study examines the saliva and dental plaque microbiome of women aged 35-65 in two groups:

postmenopausal (case) and premenopausal (control). For this purpose, Illumina Platform to sequence 16S rRNA gene regions will be used. The data will be analyzed using the QIIME2 bioinformatics tool. Serum estradiol levels will be determined by the ELISA method. The investigators will examine the relationship between microbiome data (alpha diversity, beta diversity, and relative abundance) and menopausal status, estradiol levels, and periodontal health status using linear statistical models. Clinical samples of the study will be collected at Ege University, and the laboratory studies and sequence analysis will be conducted at the Forsyth Institute in Boston.

To obtain longitudinal data besides the cross-sectional data, the investigators will contact the participants of a previous study from 2019, whose saliva, dental plaque, and serum samples are currently being stored at -80 °C, and ask them to participate for a second sampling.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 220
• Est. completion date: October 30, 2023
• Est. primary completion date: December 30, 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 35 Years to 65 Years

Eligibility

Inclusion Criteria Regularly mensturating women over 35 years of age Postmenopausal women under 65 years of age

-

Exclusion Criteria:

• Antibiotic useage in last 3 months Being in menopausal transition phase

Related Conditions & MeSH terms

• Menopause

Intervention

Diagnostic Test:
• Intraoral examination, saliva, dental plaque and serum collection.
Probing pocket depth will be defined as the distance in millimeters from the gingival margin to the base of the gingival sulcus measured using a manual probe (Michigan 0 probe with Williams Markings) in all the teeth present except for third molars. Similarly, clinical attachment level (CAL) will be measured as distance from cementoenamel junction to the base of pocket and will be recorded manually to the nearest millimeter marking on probe. 1 mililiter of saliva will be obtained by each participant. Subgingival dental plaque will be collected with sterile endodontic paperpoints from mesial sides of each natural teeth without a prostethic restoration. Serum samples will be also collected at the time of visit.

Locations

Country	Name	City	State
Turkey	Ege University	Izmir

Sponsors (2)

Lead Sponsor	Collaborator
Ege University	The Forsyth Institute

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Differences in the relative abundances of bacteria in groups, acquired by processing of Illumina sequencing data with QIIME2 bioinformatic tool.		1 year